UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

Journal of Clinical Microbiology, 2013-05, Vol.51 (5), p.1510-1516

2013

Volltextzugriff (PDF)

Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling

Journal of translational medicine, 2018-10, Vol.16 (1), p.281-281, Article 281

2018

Volltextzugriff (PDF)

Synthesis of 68Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced 68Ga as exemplified by [68Ga]Ga-PSMA-11 for prostate cancer PET imaging

Nature protocols, 2022-04, Vol.17 (4), p.980-1003

2022

Volltextzugriff (PDF)

Hepatocyte growth factor activation inhibitors (HAI‐1 and HAI‐2) regulate HGF‐induced invasion of human breast cancer cells

International journal of cancer, 2006-09, Vol.119 (5), p.1176-1183

2006

Volltextzugriff (PDF)

The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer

Clinical cancer research, 2004-01, Vol.10 (1), p.202-211

2004

Volltextzugriff (PDF)

Placenta growth factor is over-expressed and has prognostic value in human breast cancer

European journal of cancer (1990), 2005-12, Vol.41 (18), p.2819-2827

2005

Volltextzugriff (PDF)

Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target

EJNMMI radiopharmacy and chemistry, 2020-11, Vol.5 (1), p.25-25, Article 25

2020

Volltextzugriff (PDF)

Decreased Pigment Epithelium–Derived Factor Expression in Human Breast Cancer Progression

Clinical cancer research, 2006-06, Vol.12 (11), p.3510-3517

2006

Volltextzugriff (PDF)

Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy

Clinical cancer research, 2005-08, Vol.11 (16), p.6012-6019

2005

Volltextzugriff (PDF)

Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells

International journal of oncology, 2001-10, Vol.19 (4), p.857

2001

Volltextzugriff (PDF)

Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients

Clinical cancer research, 2007-06, Vol.13 (12), p.3568-3576

2007

Volltextzugriff (PDF)

Hepatocyte growth factor activation inhibitors - therapeutic potential in cancer

Anti-cancer agents in medicinal chemistry, 2010-01, Vol.10 (1), p.47-57

2010

Volltextzugriff (PDF)

Reduction of Stromal Fibroblast-induced Mammary Tumor Growth, by Retroviral Ribozyme Transgenes to Hepatocyte Growth Factor/Scatter Factor and its Receptor, c-MET

Clinical cancer research, 2003-09, Vol.9 (11), p.4274-4281

2003

Volltextzugriff (PDF)

Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer

European Journal of Cancer, 2009-06, Vol.45 (9), p.1673-1683

2009

Volltextzugriff (PDF)

Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers

Journal of clinical microbiology, 2018-01, Vol.56 (1)

2018

Volltextzugriff (PDF)

The type II transmembrane serine protease, matriptase-2: Possible links to cancer?

Anti-cancer agents in medicinal chemistry, 2010-01, Vol.10 (1), p.64-69

2010

Volltextzugriff (PDF)

The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1415-e1422

2021

Volltextzugriff (PDF)

Antagonistic Effect of NK4, a Novel Hepatocyte Growth Factor Variant, on in Vitro Angiogenesis of Human Vascular Endothelial Cells

Clinical cancer research, 1999-11, Vol.5 (11), p.3695-3703

1999

Volltextzugriff (PDF)

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

Critical reviews in oncology/hematology, 2005, Vol.53 (1), p.35-69

2005

Volltextzugriff (PDF)

Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4

Breast cancer research and treatment, 2000-02, Vol.59 (3), p.245-254

2000

Volltextzugriff (PDF)

Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer

Breast cancer research : BCR, 2005-01, Vol.7 (4), p.R402-R410, Article R402

2005

Volltextzugriff (PDF)

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells

International journal of molecular medicine, 2006-04, Vol.17 (4), p.583-590

2006

Volltextzugriff (PDF)

Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients

Angiogenesis (London), 2006-06, Vol.9 (2), p.73-81

2006

Volltextzugriff (PDF)

Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation

Journal of cellular physiology, 2008-09, Vol.216 (3), p.780-789

2008

Volltextzugriff (PDF)

Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist

Carcinogenesis (New York), 2003-08, Vol.24 (8), p.1317-1323

2003

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(116)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(63)
Humans
(48)
Female
(25)
Animals
(18)
Male
(18)
Oncology
(18)
Biological And Medical Sciences
(16)
Cell Line, Tumor
(15)
Medical Sciences
(15)
Physical Sciences
(14)
Breast Neoplasms - Pathology
(13)
Mice
(12)
Chemistry
(10)
Neoplasm Invasiveness
(10)
Reverse Transcriptase Polymerase Chain Reaction
(10)
Tumors
(10)
Adult
(9)
Breast Cancer
(9)
Gene Expression Regulation, Neoplastic
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling

Synthesis of 68Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced 68Ga as exemplified by [68Ga]Ga-PSMA-11 for prostate cancer PET imaging

Hepatocyte growth factor activation inhibitors (HAI‐1 and HAI‐2) regulate HGF‐induced invasion of human breast cancer cells

The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer

Placenta growth factor is over-expressed and has prognostic value in human breast cancer

Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target

Decreased Pigment Epithelium–Derived Factor Expression in Human Breast Cancer Progression

Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy

Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells

Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients

Hepatocyte growth factor activation inhibitors - therapeutic potential in cancer

Reduction of Stromal Fibroblast-induced Mammary Tumor Growth, by Retroviral Ribozyme Transgenes to Hepatocyte Growth Factor/Scatter Factor and its Receptor, c-MET

Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer

Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers

The type II transmembrane serine protease, matriptase-2: Possible links to cancer?

The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery

Antagonistic Effect of NK4, a Novel Hepatocyte Growth Factor Variant, on in Vitro Angiogenesis of Human Vascular Endothelial Cells

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4

Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells

Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients

Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation

Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist

Suchergebnisse filtern